Shelygin YA, Sushkov OI, Sukhina MA, Saifutdinova KR, Muratov II, Shakhmatov DG, Achkasov SI. [Effectiveness of intraperitoneal chemotherapy for t4 colon cancer].
Khirurgiia (Mosk) 2020:36-43. [PMID:
33047584 DOI:
10.17116/hirurgia202010136]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
OBJECTIVE
To determine the effect of intraperitoneal chemotherapy (IPC) with mitomycin C on expression of intraperitoneal cancer cells markers in patients with T4 colon cancer.
MATERIAL AND METHODS
For the period from January 2019 to April 2020, 65 patients with T4 colon cancer were included in prospective comparative study. There were 46 patients in the main group and 19 patients in the control group. In the main group, surgical procedure was followed by IPC with mitomycin C. No IPC was performed in the control group. An effectiveness of IPC was evaluated using CD133, CD24, CD26, CD44, CD184 markers expression in peritoneal lavages.
RESULTS
Significant between-group differences were observed for CD133 (p=0.0168), CD24 (p=0.0455) and CD44 (p=0.0012). There was a tendency to decrease in the level of CD184 expression in both groups in the second lavage (p=0.0605).
CONCLUSION
IPC in patients with T4 colon cancer can reduce the expression and proliferative potential of free cancer cells.
Collapse